147
Participants
Start Date
January 31, 2003
Study Completion Date
September 30, 2004
Clozapine
Clozapine 25 or 100 mg tablets. Patients were initially titrated over the first 10 days to 300 mg/day and remained at this dose for 1 week. Thereafter, the dose could be varied between 250 and 600 mg/day based on response and tolerability for a total treatment duration of 18 weeks
Ziprasidone
Ziprasidone 40, 60, or 80 mg capsules. Patients were initially titrated over the first 3 days to 80 mg/day, which could subsequently be increased to between 80 and 160 mg/day based on response and tolerability for a total treatment duration of 18 weeks
Pfizer Investigational Site, Torino
Pfizer Investigational Site, Montichiari (brescia)
Pfizer Investigational Site, Brescia
Pfizer Investigational Site, Trieste
Pfizer Investigational Site, Bassano del Grappa
Pfizer Investigational Site, Verona
Pfizer Investigational Site, Parma
Pfizer Investigational Site, Florence
Pfizer Investigational Site, Siena
Pfizer Investigational Site, Guardiagrele (CH)
Pfizer Investigational Site, Bari
Pfizer Investigational Site, Napoli
Pfizer Investigational Site, Reggio Calabria
Pfizer Investigational Site, Catania
Pfizer Investigational Site, Messina
Pfizer Investigational Site, Città di Castello
Pfizer Investigational Site, Cagliari
Pfizer Investigational Site, Cagliari
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Sassari
Pfizer Investigational Site
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY